Dakos Andrew has demonstrated a clear buying bias in recent months, with 22 purchases and zero sales across two companies—SWZ and TRC—since January 2026, according to SEC Form 4 filings. The bulk of activity has centered on SWZ, with purchases totaling $808,911.96 and sales amounting to $146,361.12 over 29 transactions. Notably, all sales occurred in January, while the subsequent months saw a steady accumulation of SWZ shares, including a $72,120 purchase on March 5 and a $74,625 buy on March 6. The buying spree continued through March, with multiple transactions exceeding $30,000, such as a $59,012.10 acquisition on March 2 and a $34,928 purchase on March 27.
The only other company involved, TRC, saw a single transaction—a $16,448.11 award on January 12. The absence of recent selling, coupled with the concentrated buying in SWZ, suggests a strong directional commitment to the stock. The sales in January, totaling $86,296.32 across two transactions, appear isolated, as the following months were marked exclusively by purchases. The pattern indicates a sustained accumulation strategy, with no disposals recorded beyond the early-year activity. The scale and consistency of these buys, particularly in SWZ, underscore a pronounced tilt toward increasing exposure.
AI-assisted summary